meta_pixel
Tapesearch Logo
Log in
The Highwire with Del Bigtree

ACIP MAYHEM OVER NEWBORN HEPATITIS B SHOT

The Highwire with Del Bigtree

The Highwire with Del Bigtree

Health & Fitness, Society & Culture, News

4.93.4K Ratings

🗓️ 11 December 2025

⏱️ 12 minutes

🧾️ Download transcript

Summary

Day one of this week’s Advisory Committee on Immunization Practices (ACIP) meeting revealed a stunning shift in the hepatitis B debate. For the first time, panel experts openly acknowledged they do not have the data to justify giving every newborn a hepatitis B shot on their first day of life. Hear how this new advisory group challenged inflated risk assumptions, admitted the evidence for newborn safety is surprisingly weak, and questioned why infants are expected to bear the burden for failures in adult screening and prevention. This pivotal exchange is reshaping the national conversation around vaccine policy—and the science that must support it.

Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Transcript

Click on a timestamp to play from that location

0:00.0

I want to go now to the story of the day.

0:02.0

This is the CDC's ASIP committee, the advisory committee on immunization practices.

0:06.0

They're meeting right now as we speak.

0:08.0

The entire day today is voted, is devoted, and we'll be voting on the hepatitis B recommendation,

0:16.0

the first shot given to babies' first day of life in this country.

0:20.0

And I want to make some points here that you made

0:22.0

right at the top. We have the previous chair, Martin Koldorf. He has now left. So the chairman of the

0:28.7

ASIP previously has now left for an HHS job. So he's becoming now the chief science officer

0:34.6

within the HHS planning and evaluation office. So that's kind of like the major think tank in HHS. So he's moved on to that senior position. So now we have Dr. Robert Malone as the vice chair. Dr. Kurt Milhoun, he came in on a Zoom call. So essentially Robert Malone, you'll see from the video, he's facilitating the entire meeting. And I have to say he seems like he's doing a great job. So I want to talk about

0:55.0

the hepatitis B vaccine was on the docket for last ASIP, the last ASIP meeting months ago.

1:02.2

And this is Robert Malone introing today's ASIP meeting just this morning to talk about that.

1:07.7

Take a listen. Okay. Many of you will recall that in September, ASIP deferred a vote

1:12.5

on proposed changes to the hepatitis B vaccination schedule. That decision was not about hesitation or

1:18.7

reluctance. It was about standards. Several data elements the committee requested were incomplete,

1:25.8

and the evidence did not yet meet the level of

1:28.1

clarity required for a confident, evidence-based recommendation.

1:33.2

When gaps in the evidence aburge, the responsible action is not to push forward.

1:38.3

It's to pause, review, ensure that we fully understand what the data can and cannot support and then formulate

1:46.0

independent advice to the CDC director. This is our charter.

1:51.7

So there you, and the reason we're playing these clips, and again to the audience, we're

1:55.1

watching this in real time, making these clips, shooting these out so we can report in near

2:00.4

real time on this meeting that just happened.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Highwire with Del Bigtree, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Highwire with Del Bigtree and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.